Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
36 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-02-02 | 2023-09-07 | 183419 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-06-26 | 2023-08-18 | 196476 |
| TEVA-SERTRALINE | 25MG | CAPSULE | Resolved | 2023-07-04 | 2023-08-18 | 197218 |
| TEVA-METOPROLOL | 50MG | TABLET | Resolved | 2023-02-02 | 2023-08-18 | 183383 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-06-08 | 2023-08-18 | 194103 |
| TEVA-OMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-06-08 | 2023-08-18 | 194116 |
| TEVA-NARATRIPTAN | 2.5MG | TABLET | Resolved | 2023-06-08 | 2023-08-18 | 194131 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-06-08 | 2023-08-18 | 194148 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2023-06-26 | 2023-08-18 | 196471 |
| TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2023-07-18 | 2023-08-18 | 198960 |
| TEVA-NITROFURANTOIN | 100MG | CAPSULE | Resolved | 2023-07-18 | 2023-08-18 | 199026 |
| TEVA-GABAPENTIN | 600MG | TABLET | Resolved | 2023-07-18 | 2023-08-18 | 199053 |
| TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-07-21 | 2023-08-18 | 199554 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2023-07-27 | 2023-08-18 | 200203 |
| TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2023-08-03 | 2023-08-18 | 200873 |
| TEVA-AMPHETAMINE XR | 15MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-04-27 | 2023-08-18 | 190755 |
| NOVAMOXIN | 250MG | TABLET (CHEWABLE) | Resolved | 2023-06-19 | 2023-08-18 | 195545 |
| TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2023-06-20 | 2023-08-18 | 195900 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2023-04-27 | 2023-08-18 | 190734 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2023-06-16 | 2023-08-18 | 195121 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |